市场调查报告书
商品编码
1267461
医疗保健领域的人工智能市场——按应用(医学成像/诊断,药物发现,治疗计划,医院工作流程,可穿戴设备,虚拟助手),区域和全球预测,2023-2032 年Artificial Intelligence in Healthcare Market - By Application (Medical Imaging & Diagnosis, Drug Discovery, Therapy Planning, Hospital Workflow, Wearables, Virtual Assistants), By Region & Global Forecast, 2023 - 2032 |
随着精准医疗的普及,医疗保健领域的人工智能市场预计将在 2032 年之前稳步增长。
精准医学比直觉医学更受欢迎,因为它更容易获得,简单且便宜。 因此,人工智能技术的使用正在增加,这将推动未来的市场需求。
此外,新加坡,中国等东南亚国家融资场景有利,有望推动行业发展。 正如此前报导的那样,中国国务院的目标是到 2030 年使中国成为世界上最大的创新中心。 为实现这一目标,中国政府在人工智能领域推出了多项举措。 此外,新加坡政府的宝贵贡献也将扩大市场。
基于应用,医疗保健领域的人工智能市场预计将以医学成像和诊断为特征。 到 2022 年,该部门的价值将超过 13 亿美元,预计未来几年将实现高速增长。
此外,市场进入者推出更多产品预计会对市场增长产生积极影响。 例如,2021 年 11 月,佳能医疗推出了一个名为 Altivity 的基于人工智能的品牌。 Altivity 有望提供高质量的图像和应用程序并减少扫描时间。
此外,预计医院工作流程部分在预计期间将显着增长。 由于公众生活方式的改变,全球慢性病和传染病的增加也是推动市场增长的主要因素之一。
按地区划分,由于人均医疗费用的增加和医疗系统的发展,预计亚太地区医疗保健领域的人工智能市场将显着扩大。 同样明显的是,公众的健康意识越来越强,这也有望对市场增长产生积极影响。
此外,到 2022 年,MEA 医疗保健领域的人工智能市场规模将超过 1.15 亿美元,预计这一趋势将从 2023 年持续到 2032 年。 促进人工智能在该地区医疗保健市场的应用日益广泛的主要因素是技术创新的显着增加和大数据的使用不断增加。
医疗保健市场人工智能的主要参与者包括 IBM Corporation,Sophia Genetics,AiCure,Atomwise Inc.,Insilico Medicine Inc.,APIXIO Inc.,Cyrcadia Health Inc.,NVIDIA Corporation,Butterfly Network Inc,Enlitic, Inc. iCarbonX.,Modernizing Medicine,Sens.ly Inc,Virgin plus,Nanox 等。
Healthcare artificial intelligence market is set to experience steady growth through 2032 owing to the increasing adoption of precision medicine. Precision medicine is becoming more popular than intuitive medicine as it is more accessible, simple, and less expensive. This is resulting in increasing usage of AI technology, which will drive the market demand in the upcoming time.
Besides, there has been a favorable funding scenario in Southeast Asian countries like Singapore and China which are slated to drive the industry progression. As reported, the State Council of China aims to make the country the largest center of innovation in the world by 2030. To achieve that goal, the Chinese government has launched different initiatives in the field of AI. Besides, valuable contributions from the Singapore government will also expand the market.
Based on application, the healthcare artificial intelligence market is likely to be characterized by medical imaging & diagnosis. This segment was valued at more than $1.3 billion in 2022 and is projected to foresee appreciable growth in the ensuing years.
In addition, an increasing number of product launches by key participants is bound to positively affect the market growth. To cite an instance, in November 2021, an AI-based brand called Altivity was launched by Canon Medical. Altivity is expected to supply quality images and applications and can lessen the scanning time.
Besides, the hospital workflow segment is set to grow significantly during the estimated timeframe. The increasing cases of chronic and infectious diseases across the world, mainly due to the changing lifestyle of the general populace, is among the major factors, which has fostered the market growth.
In terms of region, the healthcare artificial intelligence market in the Asia Pacific is set to expand significantly owing to the increasing per capita health expenditure and development of the healthcare system. Besides, a growing awareness about human health is clearly visible among the general populace, which will also impact the market growth positively.
In addition, the MEA healthcare artificial intelligence market amassed more than $115 million in 2022, and the trend is likely to be continued over 2023-2032 as well. Some of the major factors which will contribute to the growth in the use of Artificial Intelligence in the healthcare market in the region include a substantial growth in technological innovation and an increase in the usage of big data.
Some of the key players in the healthcare artificial intelligence market include IBM Corporation, Sophia Genetics, AiCure, Atomwise Inc., Insilico Medicine Inc., APIXIO Inc., Cyrcadia Health Inc., NVIDIA Corporation, Butterfly Network Inc, Enlitic, Inc., iCarbonX., Modernizing Medicine, Sens.ly Inc, Virgin plus, Nanox, and more.